EV Biologics, Inc. (OTCMKTS:YECO – Get Free Report) traded up 83.1% during trading on Tuesday . The stock traded as high as $0.22 and last traded at $0.17. 780 shares changed hands during mid-day trading, a decline of 76% from the average session volume of 3,277 shares. The stock had previously closed at $0.10.
EV Biologics Price Performance
The stock has a 50-day simple moving average of $0.19 and a two-hundred day simple moving average of $0.24.
About EV Biologics
EV Biologics, Inc, a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces.
See Also
- Five stocks we like better than EV Biologics
- 3 Healthcare Dividend Stocks to Buy
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- How to Find Undervalued Stocks
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for EV Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EV Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
